Morgan Stanley Integra Lifesciences Holdings Corp Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Morgan Stanley holds 5,498,527 shares of IART stock, worth $98.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,498,527
Previous 4,914,543
11.88%
Holding current value
$98.3 Million
Previous $174 Million
8.03%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding IART
# of Institutions
255Shares Held
75.5MCall Options Held
10.7KPut Options Held
57.7K-
Black Rock Inc. New York, NY11.3MShares$201 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$139 Million0.0% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$75.3 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.89MShares$69.5 Million0.02% of portfolio
-
Cooke & Bieler LP3.51MShares$62.8 Million1.07% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $1.49B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...